Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Revill

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Drug News & Perspectives|November 10, 2007
Genomics of common diseasesPeter Revill
Drug News & Perspectives|October 11, 2007
The functional significance of cerebral estrogen synthesisPeter Revill
Antiviral Therapy|February 1, 2013
New insights into how HBV manipulates the innate immune response to establish acute and persistent infectionPeter Revill, Zhenghong Yuan
Journal of Hepatology|April 17, 2016
Overview of hepatitis B viral replication and genetic variabilityShuping Tong, Peter Revill
Current Opinion in Pharmacology|September 19, 2016
Antiviral strategies to eliminate hepatitis B virus covalently closed circular DNA (cccDNA)Peter Revill, Stephen Locarnini
Gut|June 13, 2014
Viral factors and predicting disease outcomes in chronic hepatitis BPeter Revill, Stephen Locarnini
Gut|November 26, 2016
Reply: 'More viral mutants, less HBsAg clearance? One size may not fit all'Alex Thompson, Stephen Locarnini, Peter Revill
Intervirology|September 25, 2009
Clarification required for the definition of hepatitis B virus subgenotypes C1 and C2Sang Hoon Ahn, Lilly Yuen, Peter Revill
Nature Reviews. Gastroenterology & Hepatology|February 25, 2016
Global strategies are required to cure and eliminate HBV infectionPeter Revill, Barbara Testoni, Stephen Locarnini, et al.
The Journal of General Virology|January 22, 2005
Taro vein chlorosis virus: characterization and variability of a new nucleorhabdovirusPeter Revill, Xuan Trinh, James Dale, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Drug News & Perspectives|November 10, 2007
Genomics of common diseasesPeter Revill
Drug News & Perspectives|October 11, 2007
The functional significance of cerebral estrogen synthesisPeter Revill
Antiviral Therapy|February 1, 2013
New insights into how HBV manipulates the innate immune response to establish acute and persistent infectionPeter Revill, Zhenghong Yuan
Journal of Hepatology|April 17, 2016
Overview of hepatitis B viral replication and genetic variabilityShuping Tong, Peter Revill
Current Opinion in Pharmacology|September 19, 2016
Antiviral strategies to eliminate hepatitis B virus covalently closed circular DNA (cccDNA)Peter Revill, Stephen Locarnini
Gut|June 13, 2014
Viral factors and predicting disease outcomes in chronic hepatitis BPeter Revill, Stephen Locarnini
Gut|November 26, 2016
Reply: 'More viral mutants, less HBsAg clearance? One size may not fit all'Alex Thompson, Stephen Locarnini, Peter Revill
Intervirology|September 25, 2009
Clarification required for the definition of hepatitis B virus subgenotypes C1 and C2Sang Hoon Ahn, Lilly Yuen, Peter Revill
Nature Reviews. Gastroenterology & Hepatology|February 25, 2016
Global strategies are required to cure and eliminate HBV infectionPeter Revill, Barbara Testoni, Stephen Locarnini, et al.
The Journal of General Virology|January 22, 2005
Taro vein chlorosis virus: characterization and variability of a new nucleorhabdovirusPeter Revill, Xuan Trinh, James Dale, et al.
Pageof 5